Harvesting & Revenue, page-179

I believe that CLI has taken a hit on a number of fronts combined, but overall hasn't lost too much ground like others in the sector.

There was the negative publicity on social media which has been overcome - but the market has been slow to overall re-rate since. The market is also awaiting sales agreements before it re-rates a micro stock in this sector. IMO all about risk - until it is cash in the bank, something still has the potential to go wrong - even though i don't think it will.

We saw BOT botch a medical trial yesterday and it lost 52% (i was actually following them, doing some research and considering hopping on), so the market is wary of stocks in the sector. Other stocks, particularly in Canada have been on a huge down-trend. CAN as well, setting up in Mildura, have purchased a property and are looking to crop late 2020 and process their own i believe. This stock has gone from a $4 peak to $1.05 today. Has dropped from $1.60 a month ago.

All of these are contributing factors - but i am confident in management and everything they have reported to date makes complete sense and they are ticking off each step in the timeline that should be expected. We just need to be patient - all IMO. We are awaiting a first delivery announcement which includes payment and a CBD % on the deliveries to date (some portions will have different CBD % than others, but all will ave quite well as we are a cropping ag tech provider after all).

RE-Rate coming against the trend of the sector of late - IMO, just not sure how long until it happens.